Home / News / Product News

Now Available: Restat-5 "Works at the origin of CVD"

Restat is a Lipid-lowering drug.  Restat-10 mg Tablet is already available in market. Now Restat-5 mg is added. Restat is an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methylglutaryl coenzyme A to mevalonate, a precursor of cholesterol. 

Restat is indicated for- primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia), mixed dyslipidaemia (type IIb), or homozygous familial hypercholesterolaemia in patients who have not responded adequately to diet and other appropriate measures.